The global Lung Cancer Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Therapy.

Report Scope

The Lung Cancer Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Therapy Market Report

Report Metric	Details
Report Name	Lung Cancer Therapy Market
CAGR	5%
Segment by Type	Radiation Therapy Chemotherapy Targeted Therapies Immunotherapy
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company, Abbott, Akebia Therapeutics, Agennix AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Cancer Therapy Market report?

Ans: The main players in the Lung Cancer Therapy Market are GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company, Abbott, Akebia Therapeutics, Agennix AG

What are the Application segmentation covered in the Lung Cancer Therapy Market report?

Ans: The Applications covered in the Lung Cancer Therapy Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Lung Cancer Therapy Market report?

Ans: The Types covered in the Lung Cancer Therapy Market report are Radiation Therapy, Chemotherapy, Targeted Therapies, Immunotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Radiation Therapy

1.2.3 Chemotherapy

1.2.4 Targeted Therapies

1.2.5 Immunotherapy

1.3 Market by Application

1.3.1 Global Lung Cancer Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Therapy Market Perspective (2019-2030)

2.2 Lung Cancer Therapy Growth Trends by Region

2.2.1 Global Lung Cancer Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lung Cancer Therapy Historic Market Size by Region (2019-2024)

2.2.3 Lung Cancer Therapy Forecasted Market Size by Region (2025-2030)

2.3 Lung Cancer Therapy Market Dynamics

2.3.1 Lung Cancer Therapy Industry Trends

2.3.2 Lung Cancer Therapy Market Drivers

2.3.3 Lung Cancer Therapy Market Challenges

2.3.4 Lung Cancer Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Therapy Players by Revenue

3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2019-2024)

3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lung Cancer Therapy Revenue

3.4 Global Lung Cancer Therapy Market Concentration Ratio

3.4.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2023

3.5 Lung Cancer Therapy Key Players Head office and Area Served

3.6 Key Players Lung Cancer Therapy Product Solution and Service

3.7 Date of Enter into Lung Cancer Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Therapy Breakdown Data by Type

4.1 Global Lung Cancer Therapy Historic Market Size by Type (2019-2024)

4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2025-2030)

5 Lung Cancer Therapy Breakdown Data by Application

5.1 Global Lung Cancer Therapy Historic Market Size by Application (2019-2024)

5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lung Cancer Therapy Market Size (2019-2030)

6.2 North America Lung Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Lung Cancer Therapy Market Size by Country (2019-2024)

6.4 North America Lung Cancer Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Therapy Market Size (2019-2030)

7.2 Europe Lung Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Lung Cancer Therapy Market Size by Country (2019-2024)

7.4 Europe Lung Cancer Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Therapy Market Size (2019-2030)

8.2 Asia-Pacific Lung Cancer Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Lung Cancer Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Lung Cancer Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Therapy Market Size (2019-2030)

9.2 Latin America Lung Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Lung Cancer Therapy Market Size by Country (2019-2024)

9.4 Latin America Lung Cancer Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Therapy Market Size (2019-2030)

10.2 Middle East & Africa Lung Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Lung Cancer Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Lung Cancer Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction

11.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Menarini

11.2.1 Menarini Company Detail

11.2.2 Menarini Business Overview

11.2.3 Menarini Lung Cancer Therapy Introduction

11.2.4 Menarini Revenue in Lung Cancer Therapy Business (2019-2024)

11.2.5 Menarini Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Lung Cancer Therapy Introduction

11.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2019-2024)

11.3.5 Pfizer Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Lung Cancer Therapy Introduction

11.4.4 Roche Revenue in Lung Cancer Therapy Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Lung Cancer Therapy Introduction

11.5.4 Merck Revenue in Lung Cancer Therapy Business (2019-2024)

11.5.5 Merck Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Lung Cancer Therapy Introduction

11.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 Sanofi-Aventis

11.7.1 Sanofi-Aventis Company Detail

11.7.2 Sanofi-Aventis Business Overview

11.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction

11.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2019-2024)

11.7.5 Sanofi-Aventis Recent Development

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Detail

11.8.2 Eli Lilly and Company Business Overview

11.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction

11.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2019-2024)

11.8.5 Eli Lilly and Company Recent Development

11.9 Abbott

11.9.1 Abbott Company Detail

11.9.2 Abbott Business Overview

11.9.3 Abbott Lung Cancer Therapy Introduction

11.9.4 Abbott Revenue in Lung Cancer Therapy Business (2019-2024)

11.9.5 Abbott Recent Development

11.10 Akebia Therapeutics

11.10.1 Akebia Therapeutics Company Detail

11.10.2 Akebia Therapeutics Business Overview

11.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction

11.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2019-2024)

11.10.5 Akebia Therapeutics Recent Development

11.11 Agennix AG

11.11.1 Agennix AG Company Detail

11.11.2 Agennix AG Business Overview

11.11.3 Agennix AG Lung Cancer Therapy Introduction

11.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2019-2024)

11.11.5 Agennix AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

Abbott

Akebia Therapeutics

Agennix

List of Tables

Table 1. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Radiation Therapy

Table 3. Key Players of Chemotherapy

Table 4. Key Players of Targeted Therapies

Table 5. Key Players of Immunotherapy

Table 6. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Lung Cancer Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Lung Cancer Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Lung Cancer Therapy Market Share by Region (2019-2024)

Table 10. Global Lung Cancer Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Lung Cancer Therapy Market Share by Region (2025-2030)

Table 12. Lung Cancer Therapy Market Trends

Table 13. Lung Cancer Therapy Market Drivers

Table 14. Lung Cancer Therapy Market Challenges

Table 15. Lung Cancer Therapy Market Restraints

Table 16. Global Lung Cancer Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Lung Cancer Therapy Market Share by Players (2019-2024)

Table 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2023)

Table 19. Ranking of Global Top Lung Cancer Therapy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Lung Cancer Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Lung Cancer Therapy Product Solution and Service

Table 23. Date of Enter into Lung Cancer Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Lung Cancer Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Lung Cancer Therapy Revenue Market Share by Type (2019-2024)

Table 27. Global Lung Cancer Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Lung Cancer Therapy Revenue Market Share by Type (2025-2030)

Table 29. Global Lung Cancer Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Lung Cancer Therapy Revenue Market Share by Application (2019-2024)

Table 31. Global Lung Cancer Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Lung Cancer Therapy Revenue Market Share by Application (2025-2030)

Table 33. North America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Lung Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Lung Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Lung Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Lung Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Lung Cancer Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Lung Cancer Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Lung Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Lung Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Lung Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Lung Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. GlaxoSmithKline Company Detail

Table 49. GlaxoSmithKline Business Overview

Table 50. GlaxoSmithKline Lung Cancer Therapy Product

Table 51. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 52. GlaxoSmithKline Recent Development

Table 53. Menarini Company Detail

Table 54. Menarini Business Overview

Table 55. Menarini Lung Cancer Therapy Product

Table 56. Menarini Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 57. Menarini Recent Development

Table 58. Pfizer Company Detail

Table 59. Pfizer Business Overview

Table 60. Pfizer Lung Cancer Therapy Product

Table 61. Pfizer Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 62. Pfizer Recent Development

Table 63. Roche Company Detail

Table 64. Roche Business Overview

Table 65. Roche Lung Cancer Therapy Product

Table 66. Roche Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 67. Roche Recent Development

Table 68. Merck Company Detail

Table 69. Merck Business Overview

Table 70. Merck Lung Cancer Therapy Product

Table 71. Merck Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Development

Table 73. AstraZeneca Company Detail

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Lung Cancer Therapy Product

Table 76. AstraZeneca Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Development

Table 78. Sanofi-Aventis Company Detail

Table 79. Sanofi-Aventis Business Overview

Table 80. Sanofi-Aventis Lung Cancer Therapy Product

Table 81. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 82. Sanofi-Aventis Recent Development

Table 83. Eli Lilly and Company Company Detail

Table 84. Eli Lilly and Company Business Overview

Table 85. Eli Lilly and Company Lung Cancer Therapy Product

Table 86. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 87. Eli Lilly and Company Recent Development

Table 88. Abbott Company Detail

Table 89. Abbott Business Overview

Table 90. Abbott Lung Cancer Therapy Product

Table 91. Abbott Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 92. Abbott Recent Development

Table 93. Akebia Therapeutics Company Detail

Table 94. Akebia Therapeutics Business Overview

Table 95. Akebia Therapeutics Lung Cancer Therapy Product

Table 96. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 97. Akebia Therapeutics Recent Development

Table 98. Agennix AG Company Detail

Table 99. Agennix AG Business Overview

Table 100. Agennix AG Lung Cancer Therapy Product

Table 101. Agennix AG Revenue in Lung Cancer Therapy Business (2019-2024) & (US$ Million)

Table 102. Agennix AG Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lung Cancer Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Lung Cancer Therapy Market Share by Type: 2023 VS 2030

Figure 3. Radiation Therapy Features

Figure 4. Chemotherapy Features

Figure 5. Targeted Therapies Features

Figure 6. Immunotherapy Features

Figure 7. Global Lung Cancer Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Lung Cancer Therapy Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Other Case Studies

Figure 12. Lung Cancer Therapy Report Years Considered

Figure 13. Global Lung Cancer Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Lung Cancer Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Lung Cancer Therapy Market Share by Region: 2023 VS 2030

Figure 16. Global Lung Cancer Therapy Market Share by Players in 2023

Figure 17. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2023

Figure 19. North America Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Lung Cancer Therapy Market Share by Country (2019-2030)

Figure 21. United States Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Lung Cancer Therapy Market Share by Country (2019-2030)

Figure 25. Germany Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Lung Cancer Therapy Market Share by Region (2019-2030)

Figure 33. China Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Lung Cancer Therapy Market Share by Country (2019-2030)

Figure 41. Mexico Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Lung Cancer Therapy Market Share by Country (2019-2030)

Figure 45. Turkey Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Lung Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 48. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 49. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 50. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 51. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 52. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 53. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 54. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 55. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 56. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 57. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Polycythemia Vera Treatment Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0O15761

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Exosome Medical Technology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U12944

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Chronic Myeloid Leukemia Treatment Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9Z15668

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Lymphoma Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10S14319

Mon Jun 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions